Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early High Dose Therapy and Autologous Bone Marrow Transplantation in Poor Risk Intermediate/High Grade NHL
NCT00003578Phase 3Unknown
- Sponsor
- Lymphoma Trials Office
- Start
- Jan 1993
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of carmustine, etoposide, cytarabine, melphalan in non-Hodgkin lymphoma (NHL), sponsored by Lymphoma Trials Office. Status: unknown.
02
Drugs
carmustineetoposidecytarabinemelphalan
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00003578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003578.